Becker’s also spoke to UTMB’s Dr. Salim Hayek for a separate story on lessons learned over the past year. “The most profound lesson I’ve learned is that our traditional RVU-centric physician compensation models are fundamentally misaligned with academic medicine’s multi-faceted mission — they’re financially unsustainable and directly contribute to the high proportion of low-value care in our health systems,” Hayek told Becker’s.

Where a person lives can influence their recovery from a traumatic brain injury, according to a new study by UTMB’s Dr. Monique Pappadis and a team of researchers. “The intricate relationship between healthcare access and community socioeconomic factors necessitates sophisticated strategies to increase equity,” the research team concluded.

While Vitamin A has an important role in supporting the immune system, it is no substitute for a vaccine, write Drs. Megan Berman and Richard Rupp in their Vaccine Smarts column.

In recent years, the simple act of gardening has gained recognition not only for its aesthetic appeal but also for its remarkable health benefits, writes Dr. Hasan Yasin in his column for the Daily News.

Dr. Salim Hayek also spoke to Becker’s about physician compensation. “Transforming compensation systems requires both acknowledging this anxiety and demonstrating through clear data how the current approach undermines our core academic mission of patient care, education and research,” Hayek said.

“Some cardiologists, not all, have been reluctant to agree with testosterone replacement therapy because of that black box warning,” UTMB’s Dr. Thomas Blackwell told Medscape Medical News for a story on labeling changes. “With that being removed, you are going to see a big roadblock taken away so that more men can benefit from testosterone therapy.”

Quickly and accurately identifying which microbe is causing a patient’s disease is key to developing the proper treatment, write Drs. Norbert Herzog and David Niesel in their weekly Medical Discovery News column.

"We're really trying to come up with something that was more practical, easier to use, that could be used to help prevent, control, and contain outbreaks," says UTMB’s Dr. Thomas Geisbert. He and his team published research that shows the antiviral Obeldesivir could protect against an Ebola infection. This news was shared widely across the globe including in France 24, Gizmodo, Yahoo!news and others.